Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Merck
AstraZeneca
Colorcon
Dow
Express Scripts

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Litigation Details for Pfizer Inc. v. Sandoz Inc. (D. Del. 2013)

See Plans and Pricing

« Back to Dashboard

Pfizer Inc. v. Sandoz Inc. (D. Del. 2013)

Docket   Start Trial Date Filed 2013-06-21
Court District Court, D. Delaware Date Terminated 2016-04-21
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Parties ACCORD HEALTHCARE INC. USA; ALKEM LABORATORIES LTD.; AMERIGEN PHARMACEUTICALS INC.; AMNEAL PHARMACEUTICALS LLC; APOTEX INC.; HETERO LABS LIMITED; HETERO USA, INC.; IMPAX LABORATORIES INC.; LUPIN LTD.; PFIZER INC.; SANDOZ INC.; UCB PHARMA GMBH; WOCKHARDT BIO AG; WOCKHARDT USA LLC; ZYDUS PHARMACEUTICALS (USA) INC.
Patents 6,858,650; 7,384,980; 7,807,715; 7,855,230; 7,985,772; 8,088,398; 8,338,478
Attorneys Anthony Gerard Flynn , Jr.; Anuj K. Wadhwa; Benjamin J. Schladweiler; Bindu Ann George Palapura; C. Kyle Musgrove; Chad A. Landmon; Christine Dealy Haynes; Christopher Casieri; Damon Gupta; David Ellis Moore; David J. Marck; Delphine W. Knight Brown; Elizabeth M. Crompton; Erin M. Forbes; Gabriela Materassi; Heinz J. Salmen; Jack B. Blumenfeld; Jamaica P. Szeliga; James M Moriarty; Jessica M. Tyrus; John C. Phillips , Jr.; John M. Seaman; John W. Shaw; Joseph M. Reisman; Karen Cassidy; Katharine Lester Mowery; Katherine Nicole Clouse; Kelly E. Farnan; Kevin P. Burke; Krista Vink Venegas; Mary Matterer; Maryellen Noreika; Matthew S. Murphy; Megan C. Haney; Michael M. Shen; Michael R. Dzwonczyk; Paul J. Molino; Renita S. Rathinam; Richard L. Horwitz; Roy Chamcharas; Sarah Hasford; Scott Cunning; Sheila N. Swaroop; Steven J. Moore; Thad J. Bracegirdle; Thomas P. Krzeminski; Thomas P. Steindler; Vincent P. Rao , II; Wan-Shon Lo; William A. Rakoczy; William D. Hare; William O. Adams
Link to Docket External link to docket
Small Molecule Drugs cited in Pfizer Inc. v. Sandoz Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Pfizer Inc. v. Sandoz Inc. (D. Del. 2013)

Date Filed Document No. Description Snippet Link To Document
2014-07-31 106 infringement of U.S. Patent Nos. 6,858,650 (“the ʼ650 patent”), 7,384,980 (“the ʼ980 patent”), 7,855,230 (“…(“the ʼ230 patent”), 7,985,772 (“the ʼ772 patent”), and 8,338,478 (“the ʼ478 patent”) (collectively, … the ʼ980 patent, claims 1-5 of the ʼ230 patent, claims 4 and 6-8 of the ʼ772 patent, claims 6-…specification of the ʼ650 patent differs from that of the ʼ980 patent and the other three patents-in-suit (collectively…1 of the ʼ650 patent under the guise of claim construction. Claim 1 of the ʼ650 patent is a simple, straightforward External link to document
2014-09-12 123 : U.S. Patent Nos. 7,384,980, 7,855,230, 7,985,772, and 8,338,478. As such, what the inventor describes…of U.S. Patent No. 7,384,980 (“the ʼ980 patent”) (J.A. 2). Claim 1 of the ʼ650 patent is a product…with the ʼ650 patent, and issued as a series of patents, including four of the patents-in-suit here: …the entirety of claim 1 of U.S. Patent No. 6,858,650 (“the ʼ650 patent”) (J.A. 1), and the term “contact…harmony with statutory patent law principles recognizing distinct classes of patentable subject matter, and External link to document
2014-11-26 165 Infringement of Certain Claims of U.S. Patent Nos. 6,858,650, 7,384,980, 7,855,230, 7,985,772 and 8,338,478…2013 21 April 2016 1:13-cv-01110-GMS Patent None District Court, D. Delaware External link to document
2014-12-02 168 ORDER CONSTRUING THE TERMS OF U.S. PATENT NOS. 6,858,650 & 7,384,980. Signed by Judge Gregory M. …2013 21 April 2016 1:13-cv-01110-GMS Patent None District Court, D. Delaware External link to document
2014-12-09 173 Infringement of Certain Claims of U.S. Patent Nos. 6,858,650, 7,384,980, 7,855,230, 7,985,772 and 8,338,478…2013 21 April 2016 1:13-cv-01110-GMS Patent None District Court, D. Delaware External link to document
2014-12-10 177 Infringement of Certain Claims of U.S. Patent Nos. 6,858,650, 7,384,980, 7,855,230, 7,985,772, and 8,…2013 21 April 2016 1:13-cv-01110-GMS Patent None District Court, D. Delaware External link to document
2014-12-12 184 Infringement of Certain Claims of U.S. Patent Nos. 6,858,650, 7,384,980, 7,855,230, 7,985,772, and 8,…2013 21 April 2016 1:13-cv-01110-GMS Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Express Scripts
Colorcon
Mallinckrodt
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.